An individual’s response to opioids is influenced by a complex combination of genetic, molecular and phenotypic factors.
Intra- and inter-individual variations in response to mu opioids have led to the suggestion that mu-opioid receptor subtypes exist.
Scientists have now proven that mu-opioid receptor subtypes exist and that they occur through a mechanism promoting protein diversity, called alternative splicing.
The ability of mu opioids to differentially activate splice variants may explain some of the clinical differences observed between mu opioids.
This article examines how differential activation of splice variants by mu opioids occurs through alternative mu-opioid receptor binding, through differential receptor activation, and as a result of the distinct distribution of variants located regionally and at the cellular level.
CreggRRussoGGubbayA. Pharmacogenetics of analgesic drugs. Br J Pain2013; 7: 189–208.
2.
JamesS. Human pain and genetics: some basics. Br J Pain2013; 7(4): 171–178.
3.
DroneyJRileyJRossJ. Opioid genetics in the context of opioid switching. Curr Opin Support Palliat Care2012; 6(1): 10–16.
4.
BranfordRDroneyJRossJR. Opioid genetics: the key to personalized pain control?Clin Genet2012; 82(4): 301–310.
5.
FincoGPintorMSannaD. Is target opioid therapy within sight?Minerva Anestesiol2012; 78(4): 462–472.
6.
PertCBSnyderSH. Opiate receptor: demonstration in nervous tissue. Science1973; 179(4077): 1011–1014.
7.
SimonEJHillerJMEdelmanI. Stereospecific binding of the potent narcotic analgesic (3H) Etorphine to rat-brain homogenate. Proc Natl Acad Sci U S A1973; 70(7): 1947–1949.
8.
TereniusL. Stereospecific interaction between narcotic analgesics and a synaptic plasm a membrane fraction of rat cerebral cortex. Acta Pharmacol Toxicol (Copenh)1973; 32(3): 317–320.
9.
HughesJSmithTWKosterlitzHW. Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature1975; 258(5536): 577–580.
10.
HughesJ. Isolation of an endogenous compound from the brain with pharmacological properties similar to morphine. Brain Res1975; 88(2): 295–308.
11.
TereniusLWahlstromA. Search for an endogenous ligand for the opiate receptor. Acta Physiol Scand1975; 94(1): 74–81.
12.
PasternakGWGoodmanRSnyderSH. An endogenous morphine-like factor in mammalian brain. Life Sci1975; 16(12): 1765–1769.
13.
WolozinBLPasternakGW. Classification of multiple morphine and enkephalin binding sites in the central nervous system. Proc Natl Acad Sci U S A1981; 78(10): 6181–6185.
14.
LingGSSpiegelKNishimuraSL. Dissociation of morphine’s analgesic and respiratory depressant actions. Eur J Pharmacol1983; 86(3–4): 487–488.
15.
LingGSSpiegelKLockhartSH. Separation of opioid analgesia from respiratory depression: evidence for different receptor mechanisms. J Pharmacol Exp Ther1985; 232(1): 149–155.
16.
LingGSMacLeodJMLeeS. Separation of morphine analgesia from physical dependence. Science1984; 226(4673): 462–464.
17.
PaulDPasternakGW. Differential blockade by naloxonazine of two mu opiate actions: analgesia and inhibition of gastrointestinal transit. Eur J Pharmacol1988; 149(3): 403–404.
18.
HeymanJSWilliamsCLBurksTF. Dissociation of opioid antinociception and central gastrointestinal propulsion in the mouse: studies with naloxonazine. J Pharmacol Exp Ther1988; 245(1): 238–243.
19.
WangJBImaiYEpplerCM. mu opiate receptor: cDNA cloning and expression. Proc Natl Acad Sci U S A1993; 90(21): 10230–10234.
20.
ChenYMestekALiuJ. Molecular cloning and functional expression of a mu-opioid receptor from rat brain. Mol Pharmacol1993; 44(1): 8–12.
21.
EpplerCMHulmesJDWangJB. Purification and partial amino acid sequence of a mu opioid receptor from rat brain. J Biol Chem1993; 268(35): 26447–26451.
22.
ThompsonRCMansourAAkilH. Cloning and pharmacological characterization of a rat mu opioid receptor. Neuron1993; 11(5): 903–913.
23.
EvansCJKeithDEJr.MorrisonH. Cloning of a delta opioid receptor by functional expression. Science1992; 258(5090): 1952–1955.
24.
KiefferBLBefortKGaveriaux-RuffC. The delta-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization. Proc Natl Acad Sci U S A1992; 89(24): 12048–12052.
25.
ChenYMestekALiuJ. Molecular cloning of a rat kappa opioid receptor reveals sequence similarities to the mu and delta opioid receptors. Biochem J1993; 295(Pt 3): 625–628.
26.
LiSZhuJChenC. Molecular cloning and expression of a rat kappa opioid receptor. Biochem J1993; 295(Pt 3): 629–633.
27.
MengFXieGXThompsonRC. Cloning and pharmacological characterization of a rat kappa opioid receptor. Proc Natl Acad Sci U S A1993; 90(21): 9954–9958.
28.
BareLAManssonEYangD. Expression of two variants of the human mu opioid receptor mRNA in SK-N-SH cells and human brain. FEBS Lett1994; 354(2): 213–216.
29.
PanYXXuJMahurterL. Identification and characterization of two new human mu opioid receptor splice variants, hMOR-1O and hMOR-1X. Biochem Biophys Res Commun2003; 301(4): 1057–1061.
30.
PasternakGW. Multiple opiate receptors: déjà vu all over again. Neuropharmacology2004; 47(Suppl. 1): 312–323.
31.
PassettiFFerreiraCGCostaFF. The impact of microRNAs and alternative splicing in pharmacogenomics. Pharmacogenomics J2009; 9(1): 1–13.
32.
PasternakGW. Opioids and their receptors: are we there yet?Neuropharmacology2014; 76Pt B: 198–203.
33.
RossiGPanYXChengJ. Blockade of morphine analgesia by an antisense oligodeoxynucleotide against the mu receptor. Life Sci1994; 54(21): L375–L379.
34.
RossiGCStandiferKMPasternakGW. Differential blockade of morphine and morphine-6 beta-glucuronide analgesia by antisense oligodeoxynucleotides directed against MOR-1 and G-protein alpha subunits in rats. Neurosci Lett1995; 198(2): 99–102.
35.
RossiGCPanYXBrownGP. Antisense mapping the MOR-1 opioid receptor: evidence for alternative splicing and a novel morphine-6 beta-glucuronide receptor. FEBS Lett1995; 369(2–3): 192–196.
36.
SchullerAGKingMAZhangJ. Retention of heroin and morphine-6 beta-glucuronide analgesia in a new line of mice lacking exon 1 of MOR-1. Nat Neurosci1999; 2(2): 151–156.
37.
BrownGPYangKKingMA. 3-Methoxynaltrexone, a selective heroin/morphine-6beta-glucuronide antagonist. FEBS Lett1997; 412(1): 35–38.
38.
ZimprichASimonTHolltV. Cloning and expression of an isoform of the rat mu opioid receptor (rMOR1B) which differs in agonist induced desensitization from rMOR1. FEBS Lett1995; 359(2–3): 142–146.
39.
PasternakGW. Molecular insights into mu opioid pharmacology: from the clinic to the bench. Clin J Pain2010; 26(Suppl. 10): S3–S9.
40.
PanYXXuJXuM. Involvement of exon 11-associated variants of the mu opioid receptor MOR-1 in heroin, but not morphine, actions. Proc Natl Acad Sci U S A2009; 106(12): 4917–4922.
41.
PanLXuJYuR. Identification and characterization of six new alternatively spliced variants of the human mu opioid receptor gene, OPRM. Neuroscience2005; 133(1): 209–220.
42.
BolanEPanXYPasternakG. Functional analysis of MOR-1 splice variants of the mouse mu opioid receptor gene OPRM. Synapse2004; 51(1): 11–18.
43.
PanYXXuJMahurterL. Generation of the mu opioid receptor (MOR-1) protein by three new splice variants of the OPRM gene. Proc Natl Acad Sci U S A2001; 98(24): 14084–14089.
44.
XuJXuMRossiGC. Identification and characterization of seven new exon 11-associated splice variants of the rat mu opioid receptor gene, OPRM1. Mol Pain2011; 7(1): 9.
45.
XuJXuMHurdYL. Isolation and characterization of new exon 11-associated N-terminal splice variants of the human mu opioid receptor gene. J Neurochem2009; 108: 962–972.
46.
XuJXuMBolanE. Isolating and characterizing three alternatively spliced mu opioid receptor variants: mMOR-1A, mMOR-1O, and mMOR-1P. Synapse2014; 68(4): 144–152.
AbbadieCPasternakGWAicherSA. Presynaptic localization of the carboxy-terminus epitopes of the mu opioid receptor splice variants MOR-1C and MOR-1D in the superficial laminae of the rat spinal cord. Neuroscience2001; 106(4): 833–842.
49.
MajumdarSGrinnellSLe RouzicV. Truncated G protein-coupled mu opioid receptor MOR-1 splice variants are targets for highly potent opioid analgesics lacking side effects. Proc Natl Acad Sci U S A2011; 108(49): 19778–19783.
50.
XuJXuMBrownT. Stabilization of the mu-opioid receptor by truncated single transmembrane splice variants through a chaperone-like action. J Biol Chem2013; 288(29): 21211–21227.
51.
DeverSMXuRFittingS. Differential expression and HIV-1 regulation of mu-opioid receptor splice variants across human central nervous system cell types. J Neurovirol2012; 18(3): 181–190.
52.
PangGSIthninFWongYY. A non-synonymous single nucleotide polymorphism in an OPRM1 splice variant is associated with fentanyl-induced emesis in women undergoing minor gynaecological surgery. PLoS One2012; 7(11):e48416.
53.
LiuXYLiuZCSunYG. Unidirectional cross-activation of GRPR by MOR1D uncouples itch and analgesia induced by opioids. Cell2011; 147(2): 447–458.
